title: Management of ventricular arrhythmias.
abstract: Underlying causes of ventricular tachycardia (VT) or complex ventricular arrhythmias (VA) should be treated if possible. This may include beta-adrenergic blockade radiofrequency catheter ablation and automatic implantable cardioverter-defibrillators. The ACC/AHA Class I indications for an AICD are discussed. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/minute.
authors.affiliation: Cardiology Division, New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595, USA. wsaronow@aol.com
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000601:surgery*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D017147:Defibrillators, Implantable; D006801:Humans; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000601:surgery; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000601:surgery
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents